Jm. Martins et al., ACUTE MODULATION OF ACTIVE CARRIER-MEDIATED BRAIN-TO-BLOOD TRANSPORT OF CORTICOTROPIN-RELEASING HORMONE, American journal of physiology: endocrinology and metabolism, 35(2), 1997, pp. 312-319
The unidirectional brain-to-blood transport system for corticotropin-r
eleasing hormone (CRH) across the blood-brain barrier could be instrum
ental in the homeostasis of central CRH. To characterize this system,
the intracerebroventricular injection of I-125-CRH was used in mice. C
RH was rapidly transported out of the brain with a half-time disappear
ance (t(1/2)) of 15 min, much faster than albumin (t(1/2) = 50 min). K
inetic analysis revealed a saturable component with a low maximum velo
city (approximate to 0.020 nmol . min(-1) . brain(-1)) and low capacit
y (Michaelis constant approximate to 1.4 nmol/brain). Transport was in
hibited by verapamil, ouabain, and colchicine but not by cyclosporin.
Transport was increased by corticosterone and inhibited by tumor necro
sis factor-alpha and beta-endorphin. These results suggest that the sp
ecific unidirectional brain-to-blood transport system for CRH is depen
dent on energy and calcium channels, involves microtubules, is indepen
dent of the P-glycoprotein transporter, and is acutely modulated by ad
renal steroids, cytokines, and endogenous opiates. This suggests its p
articipation in the control of the stress response.